Igor Astsaturov

7.8k citations
97 papers · 2.7k indexed · h-index 32

Igor Astsaturov

94 papers receiving 2.7k citations

Peers

Igor Astsaturov
Comparison fields: 5 of 114
  • Oncology 1.1k
  • Cancer Research 512
  • Cell Biology 400
  • Molecular Biology 1.2k
  • Immunology 339
Replace Hans Morreau with:
Hans Morreau Netherlands
Thomas Bogenrieder Germany
Alexander C. Mackinnon United States
Masaya Ono Japan
H. Peter Rodemann Germany
Kaoru Mogushi Japan
Young Hwa Soung South Korea
Mahmoud Toulany Germany
John Sarantopoulos United States
Erzsébet Rásó Hungary
Igor Astsaturov relative to Hans Morreau Netherlands Hans Morreau's profile →
Citations per field
00.5×1.5×
Hans Morreau · 1×
Citations per year

Countries citing papers authored by Igor Astsaturov

Since Specialization
Citations

This map shows the geographic impact of Igor Astsaturov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Astsaturov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Astsaturov more than expected).

Fields of papers citing papers by Igor Astsaturov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Astsaturov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Astsaturov. The network helps show where Igor Astsaturov may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Igor Astsaturov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Igor Astsaturov Line = papers co-authored together Igor Astsaturov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20232
4 20230
5 202212
6 202215
7 202111
8 201853
9 201647
10 201644
11 201680
12 201529
13 201561
14 201413
15 201341
16 200960
17 200758
18 200226
19 200139
20 200175

About Igor Astsaturov

Igor Astsaturov is a scholar working on Oncology, Cancer Research and Cell Biology, having authored 97 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Lung Cancer Treatments and Mutations (14 papers), Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (10 papers), Neuroendocrine Tumor Research Advances (10 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (512 citations) and Cell Biology (400 citations). Igor Astsaturov has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Erica A. Golemis, Ilya G. Serebriiskii, Linara Gabitova, Roland L. Dunbrack, Anna S. Nikonova, Andrey Gorin, Barbara Burtness, Steven J. Cohen, Crystal S. Denlinger and Paul M. Harari. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, British Journal of Cancer and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026